These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1885 related items for PubMed ID: 15142194

  • 1. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK, Graham DY.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1051-61. PubMed ID: 15142194
    [Abstract] [Full Text] [Related]

  • 2. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep 15; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

  • 3. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A, Franceschi M, Leandro G, Paris F, Cascavilla L, Longo MG, Niro V, Andriulli A, Scarcelli C, Di Mario F.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1091-7. PubMed ID: 15569111
    [Abstract] [Full Text] [Related]

  • 4. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL, Huang B, Amer F, Christopoulos NG.
    Clin Ther; 2004 Oct 15; 26(10):1637-43. PubMed ID: 15598480
    [Abstract] [Full Text] [Related]

  • 5. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A, Ferrandez A.
    Chin J Dig Dis; 2006 Oct 15; 7(3):127-33. PubMed ID: 16808792
    [Abstract] [Full Text] [Related]

  • 6. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND.
    Ital J Gastroenterol Hepatol; 1999 Oct 15; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [Abstract] [Full Text] [Related]

  • 7. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment.
    Lanas A, Scheiman J.
    Curr Med Res Opin; 2007 Jan 15; 23(1):163-73. PubMed ID: 17257477
    [Abstract] [Full Text] [Related]

  • 8. Peptic ulcer disease today.
    Yuan Y, Padol IT, Hunt RH.
    Nat Clin Pract Gastroenterol Hepatol; 2006 Feb 15; 3(2):80-9. PubMed ID: 16456574
    [Abstract] [Full Text] [Related]

  • 9. Reducing NSAID-induced gastrointestinal complications.
    Drug Ther Bull; 2011 Feb 15; 49(2):18-21; quiz i-ii. PubMed ID: 21304164
    [Abstract] [Full Text] [Related]

  • 10. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM.
    Best Pract Res Clin Gastroenterol; 2001 Oct 15; 15(5):755-73. PubMed ID: 11566039
    [Abstract] [Full Text] [Related]

  • 11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S, Ittel TH, Wietholtz H.
    Z Gastroenterol; 2003 Aug 15; 41(8):719-28. PubMed ID: 12910426
    [Abstract] [Full Text] [Related]

  • 12. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy.
    Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D.
    J Rheumatol; 2002 Mar 15; 29(3):467-73. PubMed ID: 11908558
    [Abstract] [Full Text] [Related]

  • 13. Strategies to reduce the GI risks of antiplatelet therapy.
    Scheiman JM.
    Rev Cardiovasc Med; 2005 Mar 15; 6 Suppl 4():S23-31. PubMed ID: 17710073
    [Abstract] [Full Text] [Related]

  • 14. Helicobacter pylori infection and the use of NSAIDs.
    Bazzoli F, De Luca L, Graham DY.
    Best Pract Res Clin Gastroenterol; 2001 Oct 15; 15(5):775-85. PubMed ID: 11566040
    [Abstract] [Full Text] [Related]

  • 15. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL.
    Rheumatology (Oxford); 2003 Nov 15; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [Abstract] [Full Text] [Related]

  • 16. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary?
    Laine L.
    Rev Gastroenterol Disord; 2004 Nov 15; 4 Suppl 4():S33-41. PubMed ID: 15580145
    [Abstract] [Full Text] [Related]

  • 17. Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies.
    Lanas A, Hunt R.
    Ann Med; 2006 Nov 15; 38(6):415-28. PubMed ID: 17008305
    [Abstract] [Full Text] [Related]

  • 18. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep 15; 20(119):216-9. PubMed ID: 21954519
    [Abstract] [Full Text] [Related]

  • 19. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
    Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK.
    Am J Med; 2005 Nov 15; 118(11):1271-8. PubMed ID: 16271912
    [Abstract] [Full Text] [Related]

  • 20. Physiology and organ-related pathology of the elderly: stomach ulcers.
    Jones JI, Hawkey CJ.
    Best Pract Res Clin Gastroenterol; 2001 Dec 15; 15(6):943-61. PubMed ID: 11866486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 95.